Secretome of human umbilical cord mesenchymal stem cell maintains skin homeostasis by regulating multiple skin physiological function
Authors:
- 15 October 2022
- journal article
- research article
- Published by Springer Nature in Cell and tissue research
- Vol. 391 (1) , 111-125
Abstract
Skin is the largest organ in the body and the first defense to resist various diseases and external stimuli that easily cause infection and inflammation. Aseptic inflammation, barrier damage, and foreign aid pressure induce the destruction and damage to the skin microenvironment. Subsequently, it destroys the skin’s physiological function, leading to the maintenance and circulation of steady-state imbalance and aggravating the process of skin disorders. Our study evaluated the therapeutic potential of the secretome of human umbilical cord mesenchymal stem cells (UC-CM) for dermatological diseases in adult human skin cells, ex vivo skin tissue, and a 3D skin model. Our data suggested several advantages of UC-CM due to (1) their low cytotoxicity and sensitization properties; (2) their anti-inflammatory capacity for treating inflammatory chronic cutaneous diseases; (3) their enhanced capacity of the skin barrier for treating abnormal barrier metabolism; and (4) their positive impact on restoring skin homeostasis due to effective regulation ability of skin physiological function including cell apoptosis, detoxification, and anti-aging. We thus envisage that the possibility of harnessing the therapeutic potential of UC-CM might benefit patients suffering from inflammatory skin disorders such as atopic dermatitis, acne, and psoriasis.Keywords
Funding Information
- China National Key R&D Program (2021YFA1101500)
This publication has 89 references indexed in Scilit:
- Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell TransplantationPLOS ONE, 2013
- Cytokines and the Skin BarrierInternational Journal of Molecular Sciences, 2013
- PGE2 suppression of innate immunity during mucosal bacterial infectionFrontiers in Cellular and Infection Microbiology, 2013
- Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 2012
- Therapeutic effects of human STRO‐3‐selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemiaJournal of Cellular and Molecular Medicine, 2010
- Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptensJournal of Allergy and Clinical Immunology, 2009
- Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanismsJournal of Allergy and Clinical Immunology, 2008
- Topical Ocular Delivery of NSAIDsThe AAPS Journal, 2008
- The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disordersClinical and Experimental Immunology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001